Biophytis SaEURONEXT: ALBPS

Biophytis S A unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia

Sep 11, 2025 at 5:11 AM UTC · Issued by Biophytis SA

11 Sep 2025 07:00 CEST

Issuer

BIOPHYTIS

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1357435_PR_Detailed_Plan_SARA_VDEF.pdf

Source

Biophytis

Provider

Les Echos

Company Name

BIOPHYTIS

ISIN

FR001400OLP5

Symbol

ALBPS

Market

Euronext Growth